Xenoport, (delisted News (NASDAQ:XNPT)

DateTimeSource
Headline
07/05/20166:30AMBWArbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort
Arbor Pharmaceuticals, LLC (“Arbor”) and XenoPort, Inc. (“XenoPort”) (NASDAQ:XNPT) today announced the successful completion of Arbor’s tender offer to purchase all issued and outstanding shares of XenoPort’s common stock for $7.03 per share in cash. The tender offer expired as scheduled at 11:59 p.m., New... More...>>
06/29/20167:45AMPRNUSWhy Investors Love These Biotech's Stocks? - Cellectar Biosciences, Xenoport, Rexahn Pharma, and Tesaro
Why Investors Love These Biotech's Stocks? - Cellectar Biosciences, Xenoport, Rexahn Pharma, and Tesaro PR Newswire NEW YORK, June 29, 2016 NEW YORK, June 29, 2016 /PRNewswire/ -- The Biotech industry has seen pressure with pricing, policies, and economic uncertainties, but still it continues to present a number of great... More...>>
06/20/201612:52PMPRNUSLifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc., LinkedIn Corporation, Mines Mana...
Lifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc., LinkedIn Corporation, Mines Management, Inc., Rose Rock Midstream, L.P., STAAR Surgical Company, XenoPort, Inc. and Your Community Bankshares, Inc. PR Newswire NEW YORK, June 20, 2016 NEW YORK, June 20, 2016 /PRNewswire/... More...>>
06/16/20166:30AMBWArbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period
Arbor Pharmaceuticals, LLC (“Arbor”) and XenoPort, Inc. (“XenoPort”) (NASDAQ:XNPT) announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to the previously announced tender offer by Arbor’s wholly owned subsidiary, AP Acquisition... More...>>
06/02/20169:11AMPRNUSSHAREHOLDER ALERT: Law Offices of Marc S. Henzel Announces Investigation into the proposed sales and mergers of American Capi...
SHAREHOLDER ALERT: Law Offices of Marc S. Henzel Announces Investigation into the proposed sales and mergers of American Capital Ltd., Celator Pharmaceuticals, Inc., Demandware Inc., FEI Company, Marketo Inc., SciQuest, Inc., Textura Corporation, Westar Energy Inc., XenoPort, Inc., and Xura, Inc. PR Newswire MERION, Pa... More...>>
05/26/20164:16PMBWXENOPORT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Xenoport, Inc. (XNPT) Over the Proposed Sale...
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Xenoport, Inc. (“Xenoport” or the “Company”) (NASDAQ:XNPT) for potential breaches of fiduciary duties in connection with the sale of the Company... More...>>
05/25/20163:12PMPRNUSINVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning Whether the Sale of XenoPort, Inc. to Arbor Pharmace...
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning Whether the Sale of XenoPort, Inc. to Arbor Pharmaceuticals, LLC for $7.03 Per Share is Fair to Shareholders -- XNPT PR Newswire NEW YORK, May 25, 2016 NEW YORK, May 25, 2016 /PRNewswire/ -- The following statement is being issued by Levi &... More...>>
05/24/201610:10PMBWSHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of XenoPort, Inc. & Encourages Investors to...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of XenoPort, Inc. (Nasdaq: XNPT) (“XenoPort” or the “Company”) relating to the proposed buyout of XenoPort... More...>>
05/24/201612:31PMPRNUSSHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of XenoPort...
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of XenoPort Inc. - XNPT PR Newswire NEW YORK, May 24, 2016 NEW YORK, May 24, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XenoPort Inc. ("XenoPort" or the "Company... More...>>
05/24/201610:54AMPRNUSRyan & Maniskas, LLP Announces Investigation of XenoPort, Inc.
Ryan & Maniskas, LLP Announces Investigation of XenoPort, Inc. PR Newswire WAYNE, Pa., May 24, 2016 WAYNE, Pa., May 24, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of XenoPort, Inc. ("XenoPort" or the "Company") (NASDAQ: XNPT) concerning possible breaches... More...>>
05/23/201610:25PMPRNUSSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of XenoPort, Inc. -XNPT
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of XenoPort, Inc. -XNPT PR Newswire BALA CYNWYD, Pa., May 23, 2016 BALA CYNWYD, Pa., May 23, 2016 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of... More...>>
05/23/20165:33PMPRNUSHarwood Feffer LLP Announces Investigation of XenoPort, Inc.
Harwood Feffer LLP Announces Investigation of XenoPort, Inc. PR Newswire NEW YORK, May 23, 2016 NEW YORK, May 23, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of XenoPort, Inc. ("XenoPort" or the "Company") (NASDAQ: XNPT) concerning the proposed... More...>>
05/23/20163:19PMBWXENOPORT, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Believe the Acquisition by Arbor Pha...
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of XenoPort, Inc. (“XenoPort”) (NASDAQ GS: XNPT) concerning the acquisition by Arbor Pharmaceuticals, LLC. Under the... More...>>
05/23/201610:34AMBWXENOPORT, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Rigrodsky & Long, P.A.: Do you own shares of XenoPort, Inc. (NASDAQ GS: XNPT)? Did you purchase any of your shares prior to May 23, 2016? Do you think the proposed buyout price is too low? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against... More...>>
05/23/20168:00AMPRNUSXENOPORT (XNPT) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sal...
XENOPORT (XNPT) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of XenoPort, Inc.; Are Shareholders Getting a Fair Price? PR Newswire SAN DIEGO, May 23, 2016 SAN DIEGO, May 23, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has... More...>>
05/23/20166:30AMBWArbor Pharmaceuticals to Acquire XenoPort
Acquisition expands neurology product portfolio Enhances sales infrastructure Arbor Pharmaceuticals, LLC (Arbor) and XenoPort, Inc. (XenoPort) (NASDAQ:XNPT) announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.03 per share in cash, or a total equity value of approximately... More...>>
04/26/20161:30PMBWXenoPort to Release First Quarter Financial Results on May 5, 2016
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 5, 2016 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A replay... More...>>
03/28/20168:30AMBWDr. Reddy’s Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829
Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc. (NASDAQ: XNPT) announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral... More...>>
03/28/20161:40AMBWDr. Reddy’s Laboratories and XenoPort Enter into a U.S. Licensing Agreement for XP23829
Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc. (NASDAQ: XNPT) announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral... More...>>
03/07/20169:00AMBW#StopMakingExcuses Awareness Campaign for Restless Legs Syndrome Launches During Sleep Awareness Week 2016
Nearly 7 million Americans suffer from restless legs syndrome (RLS). For many patients suffering from moderate to severe symptoms, RLS is debilitating – disrupting sleep, influencing mood, and negatively affecting everyday life. Restless Legs Syndrome is a common and treatable neurologic disorder and the focus of a social... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20160925 07:11:10